Evidence map›Paper›PMID 28053981›Full record

ArticleBioMed research international2016

The Functional Haplotypes of

Chiang-Ting Wang, Tsung-Ming Chen, Chien-Tai Mei, Chun-Feng Chang, Li-Lian Liu, Kuo-Hsun Chiu, Tsung-Meng Wu, Yu-Ching Lan, Wen-Sheng Liu, Ya-Huey Chen and 1 more

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 1 country.

Chiang-Ting WangDivision of Urology, Department of Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.
Tsung-Ming ChenDepartment and Graduate Institute of Aquaculture, National Kaohsiung Marine University, Kaohsiung, Taiwan.
Chien-Tai MeiDivision of Urology, Department of Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.
Chun-Feng ChangDivision of Urology, Department of Medicine, Kaohsiung Armed Forces General Hospital, Kaohsiung, Taiwan.
Li-Lian LiuDepartment of Oceanography, National Sun Yat-sen University, Kaohsiung 804, Taiwan.
Kuo-Hsun ChiuDepartment and Graduate Institute of Aquaculture, National Kaohsiung Marine University, Kaohsiung, Taiwan.
Tsung-Meng WuDepartment of Aquaculture, National Pingtung University of Science and Technology, Pingtung, Taiwan.
Yu-Ching LanDepartment of Health Risk Management, China Medical University, Taichung, Taiwan.
Wen-Sheng LiuAsia-Pacific Biotech Developing Inc., Kaohsiung, Taiwan.
Ya-Huey ChenGraduate Institute of Biomedical Science, China Medical University, Taichung, Taiwan; Center for Molecular Medicine, China Medical University Hospital, Taichung, Taiwan; Cancer Biology and Drug Discovery Ph.D. Program, College of Medicine, China Medical University, Taichung, Taiwan.ORCID 0000-0002-5757-8634
Yi-Mei Joy LinInstitute of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.ORCID 0000-0002-8509-0628
Kaohsiung Armed Forces General Hospital · TWChina Medical University · TWNational Kaohsiung Marine University · TWNational Chung Hsing University · TWNational Pingtung University of Science and Technology · TWNational Sun Yat-sen University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bladder cancer is one of the major cancer types and both environmental factors and genetic background play important roles in its pathology. Kaohsiung is a high industrialized city in Taiwan, and here we focused on this region to evaluate the genetic effects on bladder cancer. Muscarinic acetylcholine receptor M3 (CHRM3) was reported as a key receptor in different cancer types.

Indexed as

Genetic Association StudiesGenetic Predisposition to DiseaseAgedFemaleGene Expression Regulation, NeoplasticGenotypeHaplotypesHumansMaleMiddle AgedPolymorphism, Single NucleotideReceptor, Muscarinic M3Receptors, MuscarinicRNA, MessengerTaiwanUrinary Bladder NeoplasmsCHRM3 protein, humanReceptor, Muscarinic M3Receptors, MuscarinicRNA, Messenger

Identifiers

PMID28053981
PMCPMC5174173
OpenAlexW2560467097

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.